The role of surgery in metastatic renal cancer continues to evolve. Although of documented benefit in patients with significant symptoms from their primary tumor and in patients with solitary (or resectable) metastatic disease, the clinical usefulness of nephrectomy in patients with unresectable metastases remains to be proved. Important clinical trials are under way to answer this question.